Okay, let's tackle this question about magnesium sulphate and respiratory depression. First, I need to recall what I know about magnesium sulfate's use and toxicity. Magnesium sulfate is commonly used in obstetrics for conditions like preeclampsia and eclampsia to prevent seizures. But it's a known CNS depressant, and one of its toxic effects is respiratory depression.

The question is asking at what concentration respiratory depression occurs. I remember that magnesium levels are monitored during administration. The therapeutic range is usually around 4-7 mEq/L, but toxicity starts at higher levels. The key here is the specific concentration that causes respiratory depression. From what I've studied, respiratory depression becomes a concern when magnesium levels exceed 10 mEq/L. Let me double-check that. Yes, sources indicate that toxicity symptoms like decreased DTRs, hypotension, and respiratory depression occur at 10-15 mEq/L, with respiratory arrest being a risk at higher levels.

Now, the options aren't provided, but the correct answer is supposed to be 10 mEq/L. The other options might be lower concentrations. For example, option A could be 5 mEq/L (therapeutic), B 8 (still within therapeutic), C 10 (correct), and D 15 (where more severe toxicity occurs). So the incorrect options are either in the therapeutic range or in the more severe toxicity range.

I should explain the core concept of magnesium's mechanism. Magnesium acts as a calcium antagonist, blocking neuromuscular transmission. At high levels, it inhibits the release of acetylcholine at the neuromuscular junction, leading to muscle weakness, including respiratory muscles. The clinical pearl here is to monitor magnesium levels and watch for signs of toxicity, especially in patients with renal impairment who can't excrete it properly. Also, calcium gluconate is the antidote for magnesium toxicity because calcium counteracts magnesium's effects on neuromuscular junctions.

**Core Concept**
Magnesium sulfate toxicity occurs at serum concentrations exceeding 2.5 mmol/L (10 mEq/L), leading to respiratory depression due to neuromuscular blockade. It acts as a calcium channel blocker, inhibiting acetylcholine release at neuromuscular junctions.

**Why the Correct Answer is Right**
Respiratory depression develops when magnesium levels reach 10 mEq/L (2.5 mmol/L). At this concentration, magnesium competitively inhibits calcium at NMDA receptors and blocks voltage-gated calcium channels, reducing neuromuscular transmission. This impairs diaphragmatic and intercostal muscle function, causing respiratory failure if uncorrected.

**Why Each Wrong Option is Incorrect**
**Option A:** 4 mEq/L is within the therapeutic range (4–7 mEq/L) for seizure prophylaxis in preeclampsia.
**Option B:** 8 mEq/L may cause early signs of toxicity (e.g., decreased deep tendon reflexes) but not respiratory depression.
**Option D:** 15 mEq/L causes profound toxicity including cardiac arrest, but the question specifically asks for the threshold of respiratory depression.

**Clinical Pearl / High-Yield Fact**
Monitor serum magnesium levels and deep tendon reflexes during therapy. Administer 10% calcium gluconate IV **immediately**

✓ Correct Answer: C. >10 mEq/L